16May/23
FDA Releases AI/ML Discussion Paper for Drug Development
In recent years, the use of artificial intelligence (AI) and machine learning (ML) has become increasingly prevalent in drug development and therapeutic areas. The U.S. Food and Drug Administration (FDA) defines AIRead More…
